Crook J - Search Results

1

Assessing Contemporary Trends in Female Speakership within Urologic Oncology.

Talwar R, Bernstein A, Jones A, Crook J, Apolo AB, Taylor JM, Burke LM, Plimack ER, Porten SP, Greene KL, Psutka SP, Smith AB. Talwar R, et al. Among authors: crook j. Urology. 2021 Apr;150:41-46. doi: 10.1016/j.urology.2020.08.006. Epub 2020 Aug 13. Urology. 2021. PMID: 32798517 Free PMC article.

2

Editorial Comment.

Crook J. Crook J. J Urol. 2019 Jun;201(6):1133. doi: 10.1097/01.JU.0000554393.69622.3c. J Urol. 2019. PMID: 30817222 No abstract available.

3

Changing management of localized prostate cancer: a comparison survey of Ontario radiation oncologists.

Martin J, Rodrigues G, Malone S, Morton G, Campbell H, Crook J. Martin J, et al. Among authors: crook j. Can J Urol. 2006 Apr;13 Suppl 2:26-33. Can J Urol. 2006. PMID: 16672125

4

A critical analysis of the long-term impact of brachytherapy for prostate cancer: a review of the recent literature.

Bowes D, Crook J. Bowes D, et al. Among authors: crook j. Curr Opin Urol. 2011 May;21(3):219-24. doi: 10.1097/MOU.0b013e3283449d52. Curr Opin Urol. 2011. PMID: 21311335 Review.

5

Results of a surgically derived nomogram to predict Gleason score upgrading applied to a cohort of patients with "favorable-risk" prostate cancer treated with permanent seed brachytherapy.

Bowes D, Crook JM, Wallace K, Evans A, Toi A, Finelli A, Jewett MA, Fleshner N, Catton C. Bowes D, et al. Urology. 2012 Sep;80(3):649-55. doi: 10.1016/j.urology.2012.03.051. Epub 2012 Jun 13. Urology. 2012. PMID: 22698474

6

American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy.

Crook JM, Haie-Meder C, Demanes DJ, Mazeron JJ, Martinez AA, Rivard MJ. Crook JM, et al. Brachytherapy. 2013 May-Jun;12(3):191-8. doi: 10.1016/j.brachy.2013.01.167. Epub 2013 Mar 1. Brachytherapy. 2013. PMID: 23453681 Free article. Review.

7

The role of intermittent androgen deprivation therapy in the management of biochemically recurrent or metastatic prostate cancer.

Jaswal J, Crook J. Jaswal J, et al. Among authors: crook j. Curr Urol Rep. 2015 Mar;16(3):11. doi: 10.1007/s11934-015-0481-2. Curr Urol Rep. 2015. PMID: 25677230 Review.

8

The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer.

Rose JN, Crook JM. Rose JN, et al. Ther Adv Urol. 2015 Jun;7(3):135-45. doi: 10.1177/1756287215576647. Ther Adv Urol. 2015. PMID: 26161144 Free PMC article. Review.

9

Prostate cancer: Elective pelvic nodal radiotherapy: is the jury still out?

Crook J. Crook J. Nat Rev Urol. 2016 Jan;13(1):10-1. doi: 10.1038/nrurol.2015.283. Epub 2015 Nov 24. Nat Rev Urol. 2016. PMID: 26597615 No abstract available.

10

Radiotherapy approaches for locally advanced penile cancer: neoadjuvant and adjuvant.

Crook J. Crook J. Curr Opin Urol. 2017 Jan;27(1):62-67. doi: 10.1097/MOU.0000000000000346. Curr Opin Urol. 2017. PMID: 27584027 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

731 results

Search Page